MD27Z - Method for treating disorders of cellular immunity caused by the ionizing radiation - Google Patents

Method for treating disorders of cellular immunity caused by the ionizing radiation Download PDF

Info

Publication number
MD27Z
MD27Z MDS20080007A MDS20080007A MD27Z MD 27 Z MD27 Z MD 27Z MD S20080007 A MDS20080007 A MD S20080007A MD S20080007 A MDS20080007 A MD S20080007A MD 27 Z MD27 Z MD 27Z
Authority
MD
Moldova
Prior art keywords
ionizing radiation
cellular immunity
treating disorders
immunity caused
day
Prior art date
Application number
MDS20080007A
Other languages
Romanian (ro)
Russian (ru)
Inventor
Ион БАХНАРЕЛ
Константин СПЫНУ
Люба КОРЕЦКИЙ
Людмила БЫРКЭ
Павел КИНТЯ
Василе ВУТКАРЁВ
Игорь СПЫНУ
Лилиана КОРЕЦКИЙ
Original Assignee
Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова filed Critical Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова
Priority to MDS20080007A priority Critical patent/MD27Z/en
Publication of MD27Y publication Critical patent/MD27Y/en
Publication of MD27Z publication Critical patent/MD27Z/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention refers to medicine, particularly to the preventive medicine.The method for treating disorders of cellular immunity caused by the ionizing radiation includes the intramuscular administration of 5% Pyridoxine solution 1 ml, once a day, per os Essentiale 2 capsules 3 times a day and Pacovirin-plus 1 tablet a day. The treatment course constitutes 90 days.
MDS20080007A 2008-10-24 2008-10-24 Method for treating disorders of cellular immunity caused by the ionizing radiation MD27Z (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDS20080007A MD27Z (en) 2008-10-24 2008-10-24 Method for treating disorders of cellular immunity caused by the ionizing radiation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDS20080007A MD27Z (en) 2008-10-24 2008-10-24 Method for treating disorders of cellular immunity caused by the ionizing radiation

Publications (2)

Publication Number Publication Date
MD27Y MD27Y (en) 2009-05-31
MD27Z true MD27Z (en) 2010-01-31

Family

ID=45094339

Family Applications (1)

Application Number Title Priority Date Filing Date
MDS20080007A MD27Z (en) 2008-10-24 2008-10-24 Method for treating disorders of cellular immunity caused by the ionizing radiation

Country Status (1)

Country Link
MD (1) MD27Z (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD410G2 (en) * 1995-08-14 1996-10-31 Tamara Vorobiova Remedy having immunomodulating activity and rehabilitating the affected function of tussue cells proliferation regulation system
MD518G2 (en) * 1995-05-30 1996-11-30 Crasnova Nadejda Human body resistance increasing remedy
MD670G2 (en) * 1996-05-08 1997-08-31 Centrul National Stiintifico-Practic De Igiena Si Epidemiologie Al Ministerului Sanatatii Din Republica Moldova Remedy with immunomodulator activity
MD3446F1 (en) * 2006-09-21 2007-12-31 Centrul National Stiintifico-Practic De Medicina Preventiva Method of HIV infection treatment
  • 2008

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD518G2 (en) * 1995-05-30 1996-11-30 Crasnova Nadejda Human body resistance increasing remedy
MD410G2 (en) * 1995-08-14 1996-10-31 Tamara Vorobiova Remedy having immunomodulating activity and rehabilitating the affected function of tussue cells proliferation regulation system
MD670G2 (en) * 1996-05-08 1997-08-31 Centrul National Stiintifico-Practic De Igiena Si Epidemiologie Al Ministerului Sanatatii Din Republica Moldova Remedy with immunomodulator activity
MD3446F1 (en) * 2006-09-21 2007-12-31 Centrul National Stiintifico-Practic De Medicina Preventiva Method of HIV infection treatment

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
A.Olinescu, L. Andries. "Tehnici imunologice". Stiinta, 1994, Chisinau, p.260-268. *
ALLISON, A. C. si altii. An Adjuvant Formulation that Selectively Elicits the Formation of Antibodies of protective Isotypes and of Cell-Mediated Immunity. Journal of Immunological Methods, 1986, vol. 95, p. 157-168 *
BYARS, N. E. si altii. Adjuvant Formulation for use in Vaccines to Elicit Both Cell-Mediated and Humoral Immunity. Vaccine, 1987, vol. 5, p. 223-228 *
M., Polimorfismul clinic al maladiilor şi particularităţile imuno- genetice la participanţii lichidării consecinţelor accidentului de la *
Moldovan M. Polimorfismul clinic al maladiilor şi particularităţile imunogenetice la participanţii lichidării consecinţelor accidentului de la Cernobâl. Autoreferat, Chişinău, 2001 *
N. Bacinschi. Preparate entomologice cu proprietăţi imunotrope. Curierul Medical nr. 6, 2010, p. 2-6 *
Sato H., Sakamura S. A better principle of tomato seeds Izolations and structure of new Furostanol Saponin. "Agr. Biol.Chem." 1973, 37(2), p.225-231. *
Лазарева Д.Н., Алехин Е. К. Стимуляторы иммунитета, Медицина, Москва, 1985, с. 416. *
Р.Ф.Петров. "Иммунология". 1982 г., Медицина, М., с. 368. Malinovskaya V.V., Kishishian E.S., Reizis A.R. Development and application of new drug of recombinat interferon al-pha-2 (viferon) for children suffering from veral infections. Inst. Symp. 100 Yers of viral. 1992. Sankt-Petersburg. *
Ю.М.Лопухин и др. "Актуальные проблемы пересадки органов", 1978 г., "Медицина", М., с. 5-13. *

Also Published As

Publication number Publication date
MD27Y (en) 2009-05-31

Similar Documents

Publication Publication Date Title
MX2022003072A (en) Use of pridopidine for treating functional decline.
PH12019502201A1 (en) Substituted indoline derivatives as dengue viral replication inhibitors
PH12015502691A1 (en) Use of high dose pridopidine for treating huntington's disease
TN2012000143A1 (en) Pharmaceutical composition, pharmaceutical dosage form, process for their preparation, methods for treating and uses thereof
PH12019502577A1 (en) Substituted indoline derivatives as dengue viral replication inhibitors
PH12019502095A1 (en) Substituted indoline derivatives as dengue viral replication inhibitors
MY198339A (en) Mono-Or Di-Substituted Indole Derivatives as Dengue Viral Replication Inhibitors
PH12018502077A1 (en) Substituted indoline derivatives as dengue viral replication inhibitors
PH12019502559A1 (en) Substituted indoline derivatives as dengue viral replication inhibitors
MX2017004618A (en) Heparan sulfate biosynthesis inhibitors for the treatment of diseases.
MX2018002906A (en) Methods of treating developmental disorders using pipradrol.
MX2018011788A (en) Substituted indoline derivatives as dengue viral replication inhibitors.
SG10201805267UA (en) Piperazine derivatives having multimodal activity against pain
MX381440B (en) PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ULCERATIVE COLITIS.
ZA202000028B (en) Use of vibegron to treat overactive bladder
MX2019006942A (en) Non-peptide oxytocin receptor agonists.
MX2014014814A (en) Pharmaceutical composition for treating inflammation and pain.
SG10201809673RA (en) Treatment of androgen deprivation therapy associated symptoms
MD27Z (en) Method for treating disorders of cellular immunity caused by the ionizing radiation
PH12014500684A1 (en) Treatment of rhinitis
MX2017006205A (en) Treatment of enteral feeding intolerance.
RU2012115039A (en) METHOD FOR TREATING CHRONIC ENDOMETRITIS
UA33293U (en) Method for treating chronic endometritis
UA89772U (en) Method for treating measles in children
MD10Z (en) Method for treating the gestational pyelonephritis

Legal Events

Date Code Title Description
ND4Y Validity of short term patent extended [from 6 to 10 years]

Expiry date: 20181024

MK4Y Short term patent expired